During the Second World War, medical academics hoped to reform medical practice and education in Great Britain, increasing doctors' sensitivity to the social and environmental causes of ill health and orientating them towards prevention. At the start of the National Health Service (NHS), central planning aimed to raise the status of isolated urban general practitioners (GPs) by grouping them in an experimental health centre. This offered a locus for social medicine, encouraging cooperation and research with local authority staff (nurses, midwives, and social workers). The Manchester case study confirms that health centre working could not be disseminated while conditions for teamwork were absent elsewhere. The failure of academic planning can be attributed to a top-down approach upon demoralized urban practice. While the participants did not form an autonomous group, economic incentives drove the growth of group practice elsewhere and made health centres superfluous to government. The College of General Practitioners developed in parallel, offering an alternative path towards an academic discipline. The case study also suggests a relationship between the emergence of groups and a psychological orientation in practice. A patient-centred model became important within teaching and gave identity to the displine, but it probably had little impact on everyday practice.

Download full-text PDF

Source
http://dx.doi.org/10.1093/shm/13.1.111DOI Listing

Publication Analysis

Top Keywords

national health
8
health service
8
social medicine
8
general practitioners
8
health centre
8
case study
8
practice
6
health
6
academic general
4
general practice
4

Similar Publications

Background: Patients with a left ventricular ejection fraction ≤ 35% are at increased risk of sudden cardiac death (SCD) within the first months after a myocardial infarction (MI). The wearable cardioverter defibrillator (WCD) is an established, safe and effective solution which can protect patients from SCD during the first months after an MI, when the risk of SCD is at its peak. This study aimed to evaluate the cost-effectiveness of WCD combined with guideline-directed medical therapy (GDMT) compared to GDMT alone, after MI in the English National Health Service (NHS).

View Article and Find Full Text PDF

Immune checkpoint inhibitors have improved the treatment of metastatic renal cell carcinoma (RCC), with the combination of nivolumab (NIVO) and ipilimumab (IPI) showing promising results. However, not all patients benefit from these therapies, emphasizing the need for reliable, easily assessable biomarkers. This multicenter study involved 116 advanced RCC patients treated with NIVO + IPI across nine oncology centers in Poland.

View Article and Find Full Text PDF

A novel genotype of Babesia microti-like group in Ixodes montoyanus ticks parasitizing the Andean bear (Tremarctos ornatus) in Ecuador.

Exp Appl Acarol

January 2025

Laboratorio de Vectores y Enfermedades Transmitidas, Departamento de Ciencias Biológicas, CENUR Litoral Norte, Universidad de la República, Salto, Uruguay.

Babesia species (Piroplasmida) are hemoparasites that infect erythrocytes of mammals and birds and are mainly transmitted by hard ticks (Acari: Ixodidae). These hemoparasites are known to be the second most common parasites infecting mammals, after trypanosomes, and some species may cause malaria-like disease in humans. Diagnosis and understanding of Babesia diversity increasingly rely on genetic data obtained through molecular techniques.

View Article and Find Full Text PDF

Background: Healthcare-based social need screening and referral (S&R) among adult populations has produced equivocal results regarding social need resource connection.

Objective: Assess the efficacy of S&R on resource connection (primary outcome) and unmet need reduction (secondary outcome).

Design: Intention-to-treat randomized controlled trial.

View Article and Find Full Text PDF

Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System.

World J Pediatr

January 2025

EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France.

Background: Data on biosimilar use in pediatric inflammatory bowel diseases (IBD) are scarce compared to the status of studies in adults, resulting in limitations in its treatment. We compared effectiveness and safety of biosimilars versus originators in this population.

Methods: We used data from the French National Health Data System to identify children (less than 18 years old at treatment initiation) initiating treatment with a biosimilar or the originator infliximab or adalimumab for Crohn's disease (CD) or ulcerative colitis (UC), from first biosimilar launch (January 2015 and October 2018, respectively) to 31 December 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!